Sie suchten nach: common terminology criteria for adverse ... (Englisch - Kroatisch)

nci common terminology criteria for adverse events
opći terminološki kriteriji za nuspojave američkog nacionalnog instituta za rak. b.

national cancer institute (nci) common terminology criteria for adverse events
opći terminološki kriteriji za nuspojave američkog nacionalnog instituta za rak. d.

toxicity grades are in accordance with national cancer institute common terminology criteria for adverse events.
b stupnjevi toksičnosti prikazani su u skladu s uobičajenim kriterijima za nuspojave national cancer institut-a.

for adverse events including
događaja koji uključuju hipotenziju,

1 nci ctcae v 4.0 = national cancer institute common terminology criteria for adverse events version 4.0
1 nci ctcae v 4.0 = zajednički kriteriji terminologije za nuspojave nacionalnog instituta za rak verzija 4.0

adverse events
nuspojava

cns adverse events
nuspojave u sŽs-u

1 grading based on national cancer institute (nci) common terminology criteria for adverse events (ctcae) v3.0
1 stupnjevi se temelje na zajedničkoj terminologiji za nuspojave (ctcae) v3.0 nacionalnog instituta za rak (nci)

adverse events including
liječenja i nuspojava.

adverse events(s)
nuspojava

adverse events associated with
rifabutina može biti potrebno

(a) the intensity of clinical adverse events graded by the common terminology criteria for adverse events v4.0 (ctc-ae).
(a) intenzitet kliničkih nuspojava stupnjevan prema zajedničkim terminološkim kriterijima za nuspojave (common terminology criteria for adverse events, verzija 4.0, ctc-ae).

risk of increased adverse events
rizik povećanja štetnih događaja

adverse events (including visual
pratiti znakovi estrogenske deficijencije.

esco would be the common terminology.
esco bi bio zajednička terminološka osnova.

dose modifications should be made if patients experience the following adverse reactions (grades refer to common terminology criteria for adverse events [ctcae 4.0]):
dozu je potrebno prilagoditi ako se u bolesnika pojave sljedeće nuspojave (stupnjevi su određeni prema verziji 4,0 zajedničkih terminoloških kriterija za nuspojave (engl.

adverse events applicable to all indications:
nuspojave primjenjive na sve indikacije:

management of ivt injection related adverse events
praćenje nuspojava povezanih uz intravitrealno ubrizgavanje

adverse events of special interest (pts)
neželjeni događaji od posebnog interesa (pt)

increase monitoring for adverse
potreban je pojačan nadzor zbog